Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 737

1.

Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study in multiple populations.

Lin GW, Xu C, Chen K, Huang HQ, Chen J, Song B, Chan JKC, Li W, Liu W, Shih LY, Chuang WY, Kim WS, Tan W, Peng RJ, Laurensia Y, Cheah DMZ, Huang D, Cheng CL, Su YJ, Tan SY, Ng SB, Tang TPL, Han K, Wang VY, Jia WH, Pei Z, Li YJ, Gao S, Shi Y, Hu Z, Zhang F, Zhang B, Zeng YX, Shen H, He L, Ong CK, Lim ST, Chanock S, Kwong YL, Lin D, Rothman N, Khor CC, Lan Q, Bei JX; International NKTCL Working Group.

Lancet Oncol. 2019 Dec 23. pii: S1470-2045(19)30799-5. doi: 10.1016/S1470-2045(19)30799-5. [Epub ahead of print]

PMID:
31879220
2.

Low-dose pembrolizumab induced complete radiologic and molecular response of posttransplant lymphoproliferative disorder presenting as classical Hodgkin lymphoma.

Sim JPY, Au-Yeung R, Kwong YL.

Ann Hematol. 2020 Feb;99(2):385-388. doi: 10.1007/s00277-019-03856-y. Epub 2019 Nov 26. No abstract available.

PMID:
31773213
3.

The value of kinetic glomerular filtration rate estimation on medication dosing in acute kidney injury.

Kwong YD, Chen S, Bouajram R, Li F, Matthay MA, Mehta KM, Glidden DV, Liu KD.

PLoS One. 2019 Nov 26;14(11):e0225601. doi: 10.1371/journal.pone.0225601. eCollection 2019.

4.

NK/T-cell lymphomas.

Tse E, Kwong YL.

Best Pract Res Clin Haematol. 2019 Sep;32(3):253-261. doi: 10.1016/j.beha.2019.06.005. Epub 2019 Jun 12. Review.

PMID:
31585625
5.

Sorafenib and omacetaxine mepesuccinate as a safe and effective treatment for acute myeloid leukemia carrying internal tandem duplication of Fms-like tyrosine kinase 3.

Zhang C, Lam SSY, Leung GMK, Tsui SP, Yang N, Ng NKL, Ip HW, Au CH, Chan TL, Ma ESK, Yip SF, Lee HKK, Lau JSM, Luk TH, Li W, Kwong YL, Leung AYH.

Cancer. 2020 Jan 15;126(2):344-353. doi: 10.1002/cncr.32534. Epub 2019 Oct 3.

PMID:
31580501
6.

Recent advances in the diagnosis and treatment of natural killer/T-cell lymphomas.

Tse E, Au-Yeung R, Kwong YL.

Expert Rev Hematol. 2019 Nov;12(11):927-935. doi: 10.1080/17474086.2019.1660640. Epub 2019 Sep 5.

PMID:
31487202
7.

Addictive response of primary cutaneous diffuse large B cell lymphoma leg type to low-dose ibrutinib.

Pang A, Au-Yeung R, Leung RYY, Kwong YL.

Ann Hematol. 2019 Oct;98(10):2433-2436. doi: 10.1007/s00277-019-03787-8. Epub 2019 Aug 24. No abstract available.

PMID:
31446456
8.

Low-dose nivolumab induced durable complete response in relapsed primary central nervous system diffuse large B cell lymphoma.

Chan TSY, Khong PL, Au-Yeung R, Kwong YL, Tse E.

Ann Hematol. 2019 Sep;98(9):2227-2230. doi: 10.1007/s00277-019-03758-z. Epub 2019 Jul 26. No abstract available.

PMID:
31346688
9.

Low-dose pembrolizumab re-treatment induced complete radiologic and molecular remission in Hodgkin lymphoma recurring from a previous relapse successfully treated by pembrolizumab.

Kwong YL, Loong F, Khong PL.

Ann Hematol. 2019 Oct;98(10):2451-2455. doi: 10.1007/s00277-019-03762-3. Epub 2019 Jul 22. No abstract available.

PMID:
31332470
10.

An Essential Role of Innate Lymphoid Cells in the Pathophysiology of Graft-vs.-Host Disease.

Shao L, Pan S, Zhang QP, Jamal M, Chen LH, Yin Q, Wu YJ, Xiong J, Xiao RJ, Kwong YL, Zhou FL, Lie AKW.

Front Immunol. 2019 Jun 6;10:1233. doi: 10.3389/fimmu.2019.01233. eCollection 2019. Review.

11.

Relationship between sun safety behaviours and modifiable lifestyle cancer risk factors and vitamin D levels.

Kalia S, Kwong YKK.

Photodermatol Photoimmunol Photomed. 2019 Nov;35(6):429-435. doi: 10.1111/phpp.12494. Epub 2019 Aug 6.

PMID:
31166633
12.

Analysis of Insole Geometry and Deformity by Using a Three-Dimensional Image Processing Technique: A Preliminary Study.

Yick KL, Lo WT, Ng SP, Yip J, Kwan HH, Kwong YY, Cheng FC.

J Am Podiatr Med Assoc. 2019 Mar;109(2):98-107. doi: 10.7547/16-116.

PMID:
31135202
13.

Oral arsenic trioxide incorporation into frontline treatment with all-trans retinoic acid and chemotherapy in newly diagnosed acute promyelocytic leukemia: A 5-year prospective study.

Gill H, Kumana CR, Yim R, Hwang YY, Chan TSY, Yip SF, Lee HKK, Mak V, Lau JSM, Chan CC, Kho B, Wong RSM, Li W, Lin SY, Lau CK, Ip HW, Leung RYY, Lam CCK, Kwong YL.

Cancer. 2019 Sep 1;125(17):3001-3012. doi: 10.1002/cncr.32180. Epub 2019 May 15.

PMID:
31090936
14.

Prediction Models for AKI: Will They Result in Improved Outcomes for AKI?

Kwong YD, Liu KD.

Clin J Am Soc Nephrol. 2019 Apr 5;14(4):488-490. doi: 10.2215/CJN.02250219. Epub 2019 Mar 27. No abstract available.

PMID:
30917995
15.

Distinct mutation spectrum, clinical outcome and therapeutic responses of typical complex/monosomy karyotype acute myeloid leukemia carrying TP53 mutations.

Leung GMK, Zhang C, Ng NKL, Yang N, Lam SSY, Au CH, Chan TL, Ma ESK, Tsui SP, Ip HW, So JCC, Ng MHL, Cheng KCK, Wong KF, Siu LLP, Yip SF, Lin SY, Lau JSM, Luk TH, Lee HKK, Lau CK, Kho B, Kwong YL, Leung AYH.

Am J Hematol. 2019 Jun;94(6):650-657. doi: 10.1002/ajh.25469. Epub 2019 Apr 16.

PMID:
30900772
16.

EBV Viral Loads in Diagnosis, Monitoring, and Response Assessment.

Kimura H, Kwong YL.

Front Oncol. 2019 Feb 12;9:62. doi: 10.3389/fonc.2019.00062. eCollection 2019. Review.

17.

Rapid versus gradual lung function decline in bronchiolitis obliterans syndrome after haematopoietic stem cell transplantation is associated with survival outcome.

Kwok WC, Liang BM, Lui MMS, Tam TCC, Sim JPY, Tse EWC, Leung AYH, Kwong YL, Lie AKW, Ip MSM, Lam DCL.

Respirology. 2019 May;24(5):459-466. doi: 10.1111/resp.13472. Epub 2019 Jan 20.

PMID:
30663178
18.

Non-traumatic splenic rupture secondary to haemorrhagic infarct in diffuse large B-cell lymphoma.

Chan VSH, Mak YH, Kwong YL, Lam SHY.

BMJ Case Rep. 2019 Jan 17;12(1). pii: e229052. doi: 10.1136/bcr-2018-229052. No abstract available.

PMID:
30659004
19.

Next-generation sequencing with a 54-gene panel identified unique mutational profile and prognostic markers in Chinese patients with myelofibrosis.

Gill H, Ip HW, Yim R, Tang WF, Pang HH, Lee P, Leung GMK, Li J, Tang K, So JCC, Leung RYY, Li J, Panagioutou G, Lam CCK, Kwong YL.

Ann Hematol. 2019 Apr;98(4):869-879. doi: 10.1007/s00277-018-3563-7. Epub 2018 Dec 4.

PMID:
30515541
20.

Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy.

Kusumoto S, Arcaini L, Hong X, Jin J, Kim WS, Kwong YL, Peters MG, Tanaka Y, Zelenetz AD, Kuriki H, Fingerle-Rowson G, Nielsen T, Ueda E, Piper-Lepoutre H, Sellam G, Tobinai K.

Blood. 2019 Jan 10;133(2):137-146. doi: 10.1182/blood-2018-04-848044. Epub 2018 Oct 19.

21.

Monitoring and Treatment of Patients Undergoing Immunotherapy With Anti-CD20 Who are Exposed to HBV.

Seto WK, Chan TS, Hwang YY, Mak LY, Wong DK, Fung J, Liu KS, Cheung KS, Lai CL, Kwong YL, Yuen MF.

Clin Gastroenterol Hepatol. 2019 Jun;17(7):1410-1412. doi: 10.1016/j.cgh.2018.09.020. Epub 2018 Sep 19.

PMID:
30243760
22.

Selection of Intravenous Fluids.

Kwong YD, Liu KD.

Am J Kidney Dis. 2018 Dec;72(6):900-902. doi: 10.1053/j.ajkd.2018.05.007. Epub 2018 Jul 3. No abstract available.

23.

Risk of viral reactivation in patients with occult hepatitis B virus infection during ruxolitinib treatment.

Gill H, Leung GMK, Seto WK, Kwong YL.

Ann Hematol. 2019 Jan;98(1):215-218. doi: 10.1007/s00277-018-3405-7. Epub 2018 Jun 26. No abstract available.

PMID:
29946910
24.

Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies.

Thanarajasingam G, Minasian LM, Baron F, Cavalli F, De Claro RA, Dueck AC, El-Galaly TC, Everest N, Geissler J, Gisselbrecht C, Gribben J, Horowitz M, Ivy SP, Jacobson CA, Keating A, Kluetz PG, Krauss A, Kwong YL, Little RF, Mahon FX, Matasar MJ, Mateos MV, McCullough K, Miller RS, Mohty M, Moreau P, Morton LM, Nagai S, Rule S, Sloan J, Sonneveld P, Thompson CA, Tzogani K, van Leeuwen FE, Velikova G, Villa D, Wingard JR, Wintrich S, Seymour JF, Habermann TM.

Lancet Haematol. 2018 Nov;5(11):e563-e598. doi: 10.1016/S2352-3026(18)30051-6. Epub 2018 Jun 18. Review. Erratum in: Lancet Haematol. 2019 Mar;6(3):e121.

25.

Mapping the contribution and strategic distribution patterns of neuroimaging features of small vessel disease in poststroke cognitive impairment.

Shi L, Zhao L, Yeung FK, Wong SY, Chan RKT, Tse MF, Chan SC, Kwong YC, Li KC, Liu K, Abrigo JM, Lau AYL, Wong A, Lam BYK, Leung TWH, Fu J, Chu WCW, Mok VCT.

J Neurol Neurosurg Psychiatry. 2018 Sep;89(9):918-926. doi: 10.1136/jnnp-2017-317817. Epub 2018 Apr 17.

PMID:
29666204
26.

Arterial Injury During Bone Marrow Aspiration: Embolization through the Biopsy Needle.

Chu F, Tse D, Chan T, Kwong YL.

J Vasc Interv Radiol. 2018 Apr;29(4):584. doi: 10.1016/j.jvir.2017.10.011. No abstract available.

PMID:
29579464
27.

Long-term outcome of relapsed acute promyelocytic leukemia treated with oral arsenic trioxide-based reinduction and maintenance regimens: A 15-year prospective study.

Gill H, Yim R, Lee HKK, Mak V, Lin SY, Kho B, Yip SF, Lau JSM, Li W, Ip HW, Hwang YY, Chan TSY, Tse E, Au WY, Kumana CR, Kwong YL.

Cancer. 2018 Jun 1;124(11):2316-2326. doi: 10.1002/cncr.31327. Epub 2018 Mar 26.

28.

Immunologic Milieu of Mature T-Cell and NK-Cell Lymphomas-Implications for Therapy.

Tse E, Kwong YL.

Curr Hematol Malig Rep. 2018 Feb;13(1):37-43. doi: 10.1007/s11899-018-0437-y. Review.

PMID:
29396703
29.

Eltrombopag in the management of aplastic anaemia: real-world experience in a non-trial setting.

Hwang YY, Gill H, Chan TSY, Leung GMK, Cheung CYM, Kwong YL.

Hematology. 2018 Aug;23(7):399-404. doi: 10.1080/10245332.2017.1422306. Epub 2018 Jan 5.

PMID:
29303047
30.

Favorable response of relapsed/refractory gray-zone lymphoma to brentuximab vedotin.

Li J, Sim J, Leung AYH, Kwong YL.

Ann Hematol. 2018 Mar;97(3):551-554. doi: 10.1007/s00277-017-3179-3. Epub 2017 Dec 2. No abstract available.

PMID:
29198035
31.

The peptidyl-prolyl isomerase PIN1 relieves cyclin-dependent kinase 2 (CDK2) inhibition by the CDK inhibitor p27.

Cheng CW, Leong KW, Ng YM, Kwong YL, Tse E.

J Biol Chem. 2017 Dec 29;292(52):21431-21441. doi: 10.1074/jbc.M117.801373. Epub 2017 Nov 8.

32.

Sequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/II NK/T-cell lymphoma.

Kwong YL, Kim SJ, Tse E, Oh SY, Kwak JY, Eom HS, Do YR, Mun YC, Lee SR, Shin HJ, Suh C, Chuang SS, Lee YS, Lim ST, Izutsu K, Suzuki R, Relander T, d'Amore F, Schmitz N, Jaccard A, Kim WS.

Ann Oncol. 2018 Jan 1;29(1):256-263. doi: 10.1093/annonc/mdx684.

33.

Complete response of age-related Epstein-Barr virus-associated polymorphic nodal lymphoproliferative disease of plasmacytic type to low-dose lenalidomide.

Hwang YY, Au-Yeung R, Lau HP, Kwong YL.

Ann Hematol. 2018 Feb;97(2):363-366. doi: 10.1007/s00277-017-3159-7. Epub 2017 Oct 24. No abstract available.

PMID:
29063179
34.

Performance of non-traditional hyperglycemia biomarkers by chronic kidney disease status in older adults with diabetes: Results from the Atherosclerosis Risk in Communities Study.

Jung M, Warren B, Grams M, Kwong YD, Shafi T, Coresh J, Rebholz CM, Selvin E.

J Diabetes. 2018 Apr;10(4):276-285. doi: 10.1111/1753-0407.12618. Epub 2017 Dec 21.

35.

Systemic trichosporonosis mimicking disseminated varicella zoster viral infection during blinatumomab therapy.

Chan TSY, Kwong YL.

Ann Hematol. 2018 Feb;97(2):371-373. doi: 10.1007/s00277-017-3153-0. Epub 2017 Oct 14. No abstract available.

PMID:
29032509
36.

Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma.

Reddy A, Zhang J, Davis NS, Moffitt AB, Love CL, Waldrop A, Leppa S, Pasanen A, Meriranta L, Karjalainen-Lindsberg ML, Nørgaard P, Pedersen M, Gang AO, Høgdall E, Heavican TB, Lone W, Iqbal J, Qin Q, Li G, Kim SY, Healy J, Richards KL, Fedoriw Y, Bernal-Mizrachi L, Koff JL, Staton AD, Flowers CR, Paltiel O, Goldschmidt N, Calaminici M, Clear A, Gribben J, Nguyen E, Czader MB, Ondrejka SL, Collie A, Hsi ED, Tse E, Au-Yeung RKH, Kwong YL, Srivastava G, Choi WWL, Evens AM, Pilichowska M, Sengar M, Reddy N, Li S, Chadburn A, Gordon LI, Jaffe ES, Levy S, Rempel R, Tzeng T, Happ LE, Dave T, Rajagopalan D, Datta J, Dunson DB, Dave SS.

Cell. 2017 Oct 5;171(2):481-494.e15. doi: 10.1016/j.cell.2017.09.027.

37.

PD1 blockade with low-dose nivolumab in NK/T cell lymphoma failing L-asparaginase: efficacy and safety.

Chan TSY, Li J, Loong F, Khong PL, Tse E, Kwong YL.

Ann Hematol. 2018 Jan;97(1):193-196. doi: 10.1007/s00277-017-3127-2. Epub 2017 Sep 6. No abstract available.

PMID:
28879531
38.

Cost-effectiveness of Phacoemulsification Versus Combined Phacotrabeculectomy for Treating Primary Angle Closure Glaucoma.

Chan PP, Li EY, Tsoi KKF, Kwong YY, Tham CC.

J Glaucoma. 2017 Oct;26(10):911-922. doi: 10.1097/IJG.0000000000000772.

PMID:
28858162
39.

Leonine facies due to Sezary syndrome: complete clinical, radiologic, and molecular remission with alemtuzumab.

Kho B, Wong HHN, Sin CF, Leung RYY, Kwong YL.

Ann Hematol. 2017 Dec;96(12):2121-2123. doi: 10.1007/s00277-017-3113-8. Epub 2017 Aug 21. No abstract available.

PMID:
28828693
40.

Primary myelofibrosis presenting in acute promyelocytic transformation.

Kwong JHY, Leung RYY, Wong MLG, Gill H, Kwong YL.

Br J Haematol. 2017 Aug;178(3):349. doi: 10.1111/bjh.14738. Epub 2017 Jul 12. No abstract available.

PMID:
28699671
41.

AKI Adjudication: Do We Need It.

Kwong YD, Liu KD.

Nephron. 2017;137(4):294-296. doi: 10.1159/000477831. Epub 2017 Jun 15. Review.

42.

Positron emission tomography computed tomography features of monomorphic epitheliotropic intestinal T-cell lymphoma.

Chan TSY, Lee E, Khong PL, Tse EWC, Kwong YL.

Hematology. 2018 Jan;23(1):10-16. doi: 10.1080/10245332.2017.1335979. Epub 2017 Jun 5.

PMID:
28581364
43.

Low-dose nivolumab-induced responses in acute lymphoblastic leukaemia relapse after allogeneic haematopoietic stem cell transplantation.

Chan TSY, Sim JPY, Kwong YL.

Ann Hematol. 2017 Sep;96(9):1569-1572. doi: 10.1007/s00277-017-3033-7. Epub 2017 Jun 1. No abstract available.

PMID:
28573313
44.

From chronic immune thrombocytopenia to severe aplastic anemia: recent insights into the evolution of eltrombopag.

Gill H, Wong RSM, Kwong YL.

Ther Adv Hematol. 2017 May;8(5):159-174. doi: 10.1177/2040620717693573. Epub 2017 Feb 1. Review.

45.

Low-dose nivolumab induced remission in refractory classical Hodgkin lymphoma.

Hwang YY, Khong PL, Kwong YL.

Ann Hematol. 2017 Jul;96(7):1219-1220. doi: 10.1007/s00277-017-3007-9. Epub 2017 Apr 22. No abstract available.

PMID:
28434018
46.

Complete radiologic and molecular response of HIV-negative primary effusion lymphoma with short-course lenalidomide.

Chan TSY, Mak V, Kwong YL.

Ann Hematol. 2017 Jul;96(7):1211-1213. doi: 10.1007/s00277-017-2995-9. Epub 2017 Apr 22. No abstract available.

PMID:
28432410
47.

Clinicopathological features and outcome of chronic lymphocytic leukaemia in Chinese patients.

Chan TS, Lee YS, Del Giudice I, Marinelli M, Ilari C, Cafforio L, Guarini A, Tan D, Phipps C, Goh YT, Hwang W, Goh AZ, Siu LL, Wu S, Ha CY, Lin SY, Kwok CH, Lau CK, Wong KF, Foà R, Kwong YL, Tse E.

Oncotarget. 2017 Apr 11;8(15):25455-25468. doi: 10.18632/oncotarget.16037.

48.

Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2.

Moffitt AB, Ondrejka SL, McKinney M, Rempel RE, Goodlad JR, Teh CH, Leppa S, Mannisto S, Kovanen PE, Tse E, Au-Yeung RKH, Kwong YL, Srivastava G, Iqbal J, Yu J, Naresh K, Villa D, Gascoyne RD, Said J, Czader MB, Chadburn A, Richards KL, Rajagopalan D, Davis NS, Smith EC, Palus BC, Tzeng TJ, Healy JA, Lugar PL, Datta J, Love C, Levy S, Dunson DB, Zhuang Y, Hsi ED, Dave SS.

J Exp Med. 2017 May 1;214(5):1371-1386. doi: 10.1084/jem.20160894. Epub 2017 Apr 19.

49.

The diagnosis and management of NK/T-cell lymphomas.

Tse E, Kwong YL.

J Hematol Oncol. 2017 Apr 14;10(1):85. doi: 10.1186/s13045-017-0452-9. Review.

50.

A cross-sectional study on compliance with topical glaucoma medication and its associated socioeconomic burden for a Chinese population.

Lui MH, Lam JC, Kwong YL, Wong TS, Cheung PL, Lai SS, Yuen PL, Lam WY, Chan HY, Wong YF, Lai JS, Shih KC.

Int J Ophthalmol. 2017 Feb 18;10(2):293-299. doi: 10.18240/ijo.2017.02.18. eCollection 2017.

Supplemental Content

Support Center